MedTrace Logo

Treatment of Rotator Cuff Tears With Platelet Rich Plasma

NCT06481046 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-07-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of dual platelet rich plasma (PRP) injections into the rotator cuff insertion and the area of the tendon proximal to the insertion.

Conditions

  • Rotator Cuff Tears
  • Rotator Cuff Tendinitis

Interventions

BIOLOGICAL

Platelet Rich Plasma (PRP)

Platelet Rich Plasma (PRP) prepared from patient blood, spun twice to concentrate platelets. 45 cc of initial blood resulting in 4cc of injectable PRP.

Sponsors & Collaborators

  • The Foundation for Orthopaedics and Regenerative Medicine

    lead OTHER

Principal Investigators

  • Chadwick Prodromos, MD · Illinois Sportsmedicine and Orthopaedic Centers

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-23
Primary Completion
2015-01-25
Completion
2015-01-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06481046 on ClinicalTrials.gov